Interaction of the endocrine system with inflammation: a function of energy and volume regulation
Open Access
- 13 February 2014
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 16 (1) , 1-15
Abstract
During acute systemic infectious disease, precisely regulated release of energy-rich substrates (glucose, free fatty acids, and amino acids) and auxiliary elements such as calcium/phosphorus from storage sites (fat tissue, muscle, liver, and bone) are highly important because these factors are needed by an energy-consuming immune system in a situation with little or no food/water intake (sickness behavior). This positively selected program for short-lived infectious diseases is similarly applied during chronic inflammatory diseases. This review presents the interaction of hormones and inflammation by focusing on energy storage/expenditure and volume regulation. Energy storage hormones are represented by insulin (glucose/lipid storage and growth-related processes), insulin-like growth factor-1 (IGF-1) (muscle and bone growth), androgens (muscle and bone growth), vitamin D (bone growth), and osteocalcin (bone growth, support of insulin, and testosterone). Energy expenditure hormones are represented by cortisol (breakdown of liver glycogen/adipose tissue triglycerides/muscle protein, and gluconeogenesis; water retention), noradrenaline/adrenaline (breakdown of liver glycogen/adipose tissue triglycerides, and gluconeogenesis; water retention), growth hormone (glucogenic, lipolytic; has also growth-related aspects; water retention), thyroid gland hormones (increase metabolic effects of adrenaline/noradrenaline), and angiotensin II (induce insulin resistance and retain water). In chronic inflammatory diseases, a preponderance of energy expenditure pathways is switched on, leading to typical hormonal changes such as insulin/IGF-1 resistance, hypoandrogenemia, hypovitaminosis D, mild hypercortisolemia, and increased activity of the sympathetic nervous system and the renin-angiotensin-aldosterone system. Though necessary during acute inflammation in the context of systemic infection or trauma, these long-standing changes contribute to increased mortality in chronic inflammatory diseases.Keywords
This publication has 150 references indexed in Scilit:
- The Insulin-Like Growth Factor System in BoneEndocrinology and Metabolism Clinics of North America, 2012
- Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiologyJournal of Molecular Medicine, 2012
- The renin–angiotensin–aldosterone system and glucose homeostasisTrends in Pharmacological Sciences, 2011
- Endocrine Regulation of Male Fertility by the SkeletonCell, 2011
- Angiotensin II revisited: new roles in inflammation, immunology and agingEMBO Molecular Medicine, 2010
- Sensory and sympathetic nervous system control of white adipose tissue lipolysisMolecular and Cellular Endocrinology, 2010
- Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulationTrends in Endocrinology & Metabolism, 2010
- Reawakened interest in type III iodothyronine deiodinase in critical illness and injuryNature Clinical Practice Endocrinology & Metabolism, 2008
- Protein hormones and immunityBrain, Behavior, and Immunity, 2007
- Neural regulation of innate immunity: a coordinated nonspecific host response to pathogensNature Reviews Immunology, 2006